Febuxostat Krka الاتحاد الأوروبي - الدانماركية - EMA (European Medicines Agency)

febuxostat krka

krka, d.d., novo mesto - febuxostat - hyperuricemia; gout - antigout præparater - febuxostat krka er indiceret til behandling af kronisk hyperuricaemia i forhold, hvor urat deposition har allerede fundet sted (herunder en historie, eller tilstedeværelsen af, tophus og/eller arthritis urica). febuxostat krka er indiceret hos voksne.

Tavlesse الاتحاد الأوروبي - الدانماركية - EMA (European Medicines Agency)

tavlesse

instituto grifols s.a. - fostamatinib dinatrium - trombocytopeni - andre systemiske hemostatics - tavlesse er indiceret til behandling af kronisk immun trombocytopeni (itp) hos voksne patienter, der er refraktære over for andre behandlinger.

Lumykras الاتحاد الأوروبي - الدانماركية - EMA (European Medicines Agency)

lumykras

amgen europe bv - sotorasib - carcinom, ikke-småcellet lunge - antineoplastiske midler - lumykras as monotherapy is indicated for the treatment of adults with advanced non-small cell lung cancer (nsclc) with kras g12c mutation and who have progressed after at least one prior line of systemic therapy.

Teriflunomide Accord الاتحاد الأوروبي - الدانماركية - EMA (European Medicines Agency)

teriflunomide accord

accord healthcare s.l.u. - teriflunomide - multipel sklerose, recidiverende-remitterende - immunosuppressants, selektiv immunosuppressive - teriflunomide accord is indicated for the treatment of adult patients and paediatric patients aged 10 years and older with relapsing remitting multiple sclerosis (ms) (please refer to section 5. 1 for important information on the population for which efficacy has been established).